Seeing is Believing: Nutrients for Visual Performance
Session Track: Healthier Living
Session Date: Wednesday, February 27, 2013; 12:45 - 1:45 p.m.
The Age-Related Eye Disease Study (AREDS) demonstrated beneficial effects of oral supplementation with antioxidants vitamin C, vitamin E, beta-carotene, and zinc on the development of advanced age-related macular degeneration (AMD). AREDS2 was designed to assess the effect of supplementation with macular xanthophylls (lutein & zeaxanthin) and/or omega-3 fatty acids (DHA and EPA) in reducing the risk of developing AMD and cataracts. AREDS2 will be completed mid-year 2013. The study results will be widely distributed, driving increased awareness of the role of lutein, zeaxanthin, DHA, EPA, and other antioxidants among consumers. Through this session, you learn about the natural history and risk factors of AMD. You will also explore the role of micronutrients in maintaining visual performance in healthy adults. Finally, you will review population demographics affecting the demand for visual performance products.
Michael McBurney, Ph.D., Head of Scientific Affairs, DSM Nutritional Products
Billy R. Hammond, Ph.D., Professor, Brain and Behavioral Sciences Program Psychology, University of Georgia
Stuart Richer, O.D., Ph.D., FAAO, Director, Ocular Preventive Medicine Laboratory, Captain James A Lovell Federal Health Care Center Eye Clinic